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A B S T R A C T 
Introduction: Febrile neutropenia have a high morbidity and mortality impact for the 
patient. The mortality rate of febrile neutropenia in 2002 was 38.8%, while it was 
27.3% in 2009. The difference in mortality rates could be caused by several factors such 
as availability of the Neutropenic Fever Management Guidelines in 2006, in addition to 
infrastructure, human resources and equipment. This study aims to determine the role 
of guideline availibility and other factors to cancer mortality rate in the 
immunocompromised isolation room of Dharmais Hospital.  
Methods: This study was a cross-sectional retrospective study which investigate 
mortality rates and compare with adherence to febrile neutropenia guidelines for the 
period 2008-2012. Data were taken from the patient's medical record file, and then 
analysed using univariate and bivariate analysis. 
Results: The mortality rate in the period 2008-2012 was 20.7%. The correlation 
between age, sex, and degree of risk factor on mortality was not significantly different 
(p=0,409, p=0,404, and p=0,324). The proportion of deaths was higher in patients 
borne by third parties (26.8%) than in the case of personal (10%) although not 
statistically significant (p=0,065). From the three types of adherence, only one had a 
significant effect of adherence to treatment flow (p=0,033).  
Conclusions: The availibility of management guideline can reduce mortality rate of 
febrile neutropenia even though from the three types of adherence, only one had a 
significant effect of adherence to treatment flow (p=0,033). 
 
 
 
INTRODUCTION 
 
Febrile neutropenia (FN) is defined as an oral 
temperature >38.5
o
C or two consecutive readings of 
>38.0
o
C for 2 hours and an absolute neutrophil count 
<0.5x10
9
/l, or expected to fall below 0.5x10
9
/l (1). 
Febrile neutropenia is a common complication in cancer 
patients who are undergoing treatment and may have 
impacts on morbidity and mortality (1-3). Rates of 
neutropenia who receive chemotherapy for solid 
tumors was 5-10%, whereas patients with hematological 
malignancy have rates more than 20%, and incidence in 
patients who have bone marrow transplant was 70-
100% (4).  Dharmais Hospital-National Cancer Center, 
Jakarta recorded febrile neutropenia mortality rate in 
1999, 2000, and 2002 in was 12.5%, 22.5%, and 38.8%, 
respectively. While in Indonesia, there is no national 
data about the magnitude of neutropenic febrile 
mortality rate (5). 
Mortality rate due to neutropenic fever is increasing, 
except in 2009, there was a considerable decrease in 
mortality rate. From 38.8% in 2002 became 27.3% in 
2009. The difference in mortality rate may be due to 
several factors, including the availability of guideline on 
neutropenic fever in 2006, in addition to infrastructure, 
human resources, equipment, and systems (6). 
The current management of neutropenia includes 
modification of chemotherapy doses, prolonged dose 
interval, and primary prophylaxis with recombinant G-
CFS (7). Guidelines of FN in cancer patients itself aims to 
achieve the same perception and understanding of 
neutropenic fever management in Indonesia, more 
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effective, safe, efficient and rational use of antibiotics, 
avoid accelerated antibiotic resistance, and obtain 
empirical data that can be continuously updated (6). 
The more detailed clarification and evaluation about 
guidelines of febrile neutropenia management in 
isolation room, Dharmais Hospital-National Cancer 
Center which was enforced since 2006 is required. This 
evaluation should have an outcome in mortality rate 
and factors that influence. The aim of this study is to 
obtain the role of management guideline availability 
and other factors in mortality rate of neutropenic fever 
patients in Dharmais Hospital-National Cancer Center in 
the year 2008-2012.  
 
METHODS 
 
This was a retrospective, cross-sectional study using 
secondary data from Dharmais Hospital-National Cancer 
Center in the period between 2008-2012. The data were 
obtained from medical records of patients who were 
diagnosed with febrile neutropenia in Dharmais 
Hospital-National Cancer Center.  
Inclusion criteria for subjects were being treated in 
isolation room; having fever (axillary temperature ≥38
0
C 
at two measurements within an hour or more for solid 
tumor, ≥37.5
0
C for hematologic cancer, or ≥38.3
0
C at 
first measurement and no signs of non-infection); and 
being diagnosed with neutropenia (neutrophils <500 
cells/mm
3
 or <1000 cells/mm
3
 with downward trend 
towards 500 cells/mm
3
 in next two days). While 
exclusion criteria of this study were incomplete data, 
both related to recording in medical record or loss of 
data in the medical record. Data of patients that met 
the inclusion criteria and avoid the exclusion criteria 
were collected and then tabulated. The degree of risk 
factor was based on Guideline of FN Management.  
The subjects were then categorized in the three 
categories, low risk: solid tumors, using conventional 
chemotherapy, no comorbidity, brief neutropenia (3 
days), no signs of severe infection, no signs of sepsis or 
shock; moderate risk: solid tumors or hematological 
malignancies, using intensive chemotherapy 
with/without comorbidity, neutropenia was lasting 3-7 
days, with/without the signs of clinical infection, 
with/without the signs os sepsis or shock; and high risk: 
hematological malignancy, using agresive 
chemotherapy/Peripheral Blood Stem Cell Transplant 
(PBSCT)/Bone Marrow Transplantion (BMT), 
with/without comorbidity, long-term neutropenia (≥7 
days), with/without the sign of clinical infection, and 
with/without the signs of sepsis of shock. 
The data of compliance was scored to perform 
statistical analysis. The indepedent numerical variables 
were tested using 2 mean differences, while 
independent categorical variable were tested using Chi 
square, Fischer’s Exact Test, and Pearson Chi Square. 
Multivariate analysis were used to find correlation 
between all of independent variables towards 
dependent variable if there were more than one 
variable that statistically significant.    
The variables seen in this study were medication 
flow adherence, medication principal adherence, 
initiation or termination of medication, age, gender, 
degree of neutropenic fever, and cost capability. All of 
these factors were corelated with mortality rate. 
 
RESULTS 
 
The amount of FN cases which were obtained 
through patient registration in isolation room 
throughout 2008-2012 were 212. Data which did not 
meet fever criteria were 43 cases, neutropenia criteria 
were 2 cases, and incomplete data were 56 cases. So 
total data that could be processed was 111 cases. 
 
Characteristics of Subjects Demography 
The mean of age was 37.8 years (SD 13.8). The 
youngest was 13 and the oldest was 70. Then subjects 
were divided into two groups. Younger patients (13-38) 
were 58 patients (52.3%) and the rest (47.7%) were over 
38 years old. In this study, men (57.7%) are more likely 
to have neutropenic fever than women (42.3%). 
Neutropenic fever patients which have the third party 
as person in charge were 64%. The guarantors as the 
third party include Jaminan Perusahaan, Asuransi, 
Askes, Jamkesda, and Jamkesmas. Based on the degree 
of risk factor, high risk became the most commonly 
obtained.  
 
Characteristics of Physician Compliance on Guideline of 
Neutropenic Fever Management 
Physician compliance of management algorithm was 
based on Guideline of FN Management that includes 5 
parameters: 1. empirical antibiotics utilization at the 
start of treatment according to degree of risk; 2. 
replacement of the type of antibiotic in case of 
worsening after 72 hours; 3. examination for re-
evaluation after 72 hours; 4. administration of anti-
fungal drugs according to degree of risk; 5. termination 
antibiotic/anti-fungal treatment according to degree of 
risk.  
While parameters of physician compliance on 
treatment principal are: 1. start antibiotic as soon as 
possible; 2. empirical according to guideline; 3. 
utilization of bactericidal antibiotic, not bacteriostatic, 
and; 4. utilization of broad-spectrum antibiotic. Both 
groups of parameter were scored, 0 (zero) if it is not 
appropriate and 5 (five) if it is most appropriate. 
Categorized as obedient if the total score is ≥15. 
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Table 1. Relationship between adherence to Guideline of neutropenic fever management and mortality rate 
Variable of compliance 
Number of life 
N (%) 
Number of death  
N (%) 
P value 
Management algorithm 
Obedient 
Disobedient 
 
71 (84,5) 
17 (63,0) 
 
13 (15,5) 
10 (37,0) 
 
0,033* 
Treatment principal 
Obedient 
Disobedient 
 
70 (77,8) 
18 (85,7) 
 
20 (22,2) 
3 (14,3) 
 
0,556** 
Starting treatment 
Obedient 
Disobedient 
 
70 (77,8) 
18 (85,7) 
 
20 (22,2) 
3 (14,3) 
 
0,556* 
*Chi-Square Test 
**Fisher’s Exact Test 
 
Table 2. Relationship between other factors and mortality rate 
Variable 
Number of life 
N (%) 
Number of death 
N (%) 
P value 
Group of age: 
13-38 years old 
>38 years old 
 
48 (82,8) 
40 (75,5) 
 
10 (17,2) 
13 (24,5) 
0,477* 
Gender: 
Men 
Women 
 
35 (74,5) 
53 (82,8) 
 
12 (25,5) 
11 (17,2) 
0,404* 
Person in charge 
Personal 
Third party 
 
36 (90,0) 
52 (73,2) 
 
4 (10,0) 
19 (26,8) 
0,065* 
The degree of risk factor 
Low  
Moderate 
High 
 
5 (100) 
3 (100) 
80 (77,7) 
 
0 (0) 
0 (0) 
23 (22,3) 
0,324** 
*Chi Square Test 
**Fisher’s Exact Test 
 
The Doctors who adhere to the management 
algorithm (67.6%) were more than those who do not 
(32.4%). As well as management algorithm, doctors who 
adhere to treatment principal (81.1%) were more than 
those who do not (18.9%) (Table 2). 
For the starting treatment criteria, the parameter 
used started at <24 hours are obedient and started at 
>24 hours are disobedient. Doctors who adhere to 
starting treatment (81.1%) were higher than those who 
do not (18.9%). 
 
Number of Cases 
Life cases (79.3%) were more than mortality cases 
(20.7%). This data showed that the number of FN 
related death cases in Dharmais Hospital-National 
Cancer Center at the period 2008-2012 was 20.7%. 
 
Data Analysis 
This study found that adherence to management 
algorithm had a significant effect on mortality rate 
compared to disobedience. Mortality rate in obedient 
cases was 15.5% and disobedient was 37% (p=0,033). 
While the adherence to treatment principle and starting 
of treatment had no significant effect on mortality rate 
of neutropenic fever (p=0,556 and p=0,556, 
respectively) (Table 1). 
Other factors that were seen in this study were age, 
gender, a person in charge, and degree of risk. All of 
these factors had no significant effect in neutropenic 
fever mortality rate (p>0,05) (Table 2).  
 
DISCUSSION 
 
Data that could be analyzed from isolation room 
during the period of 2008-2012 were 111 data (52.35%). 
Data were excluded because of avoidance of the criteria 
for neutropenic fever (21.2%) and data incompleteness 
(26.45%). This problem occurred due to medical record 
documents that in the 10 years period were not used 
anymore, considered to be inactive and would be 
transferred to the warehouse. In addition, the 
neutropenic fever diagnosis was rarely written as a 
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diagnosis, both primary or secondary diagnose in the 
medical record. 
Clinical guidelines are essential if problems are 
frequent or costly. There are wide variations in 
management practices with sufficient scientific evidence 
for optimal implementation. Guidelines of neutropenic 
fever management was qualified as a good clinical guide 
and can be implemented because it met most of 
prescribed requirements, i.e. certified fields which are 
clinically relevant; based on randomized controlled 
trials; the intended target was very clear, easy to 
understand, supported by resources, and as a tool for 
clinical staffs to provide the best service to the patient. 
The three items that were not-fulfilled have been 
measured, namely the improvements, continous 
update, and reward system (8). 
The mortality rate in isolation room at the 
observation period after the availability of neutropenic 
fever guideline was decreased (20.7%) compared to the 
previous data in 2000 (22.5%) and 2002 (38.8%). 
However, these numbers are still higher compared with 
Europe and America. The mortality rate becomes very 
important related to service quality. Based on the 
Indonesian Ministry of Health, one of the indicators in 
hospital service quality assessment is Gross Death Rate 
(GDR). GDR is the total count of mortality rate that 
occurs both before and after 48 hours compared to 
1000 outpatients (6). 
Although the mortality rate was higher in older age 
and women, statistically age and gender differences did 
not significantly correlates to mortality rate (p=0,409 
and p=0,404). Its relation to physical and emotional 
condition still needs to be proven (9). Age, gender, and 
type of chemotherapy actually are marginally significant 
factors. 
The proportion of death cases was higher in patients 
who bear a third party (26.8%) than personal (10%), 
although the difference is not statistically significant 
(p=0,065). This is caused by a third party that did not 
fully warrant the cost. They used cost-sharing system, so 
patients with financial constraints would face treatment 
problems, such as the selection of antibiotics and other 
unaccounted examinations. 
In terms of degree of risk factors, the mortality rate 
was higher in high-risk group (22.3%) compared to 
moderate (0%) or low-risk group (0%), although the 
comparison is not statistically significant. It could be 
understood because most cases which were treated in 
isolation room were acute leukaemia (90%). High 
frequency of mortality rate in high-risk group may be 
due to the availability of some equipment, such as 
sterile rooms, human resources, and better service 
system including the availability of neutropenic fever 
guideline. 
This study demonstrated that adherence to 
management algorithm (33.3%) has a very significant 
effect on mortality rate (p=14.7%) compared to 
disobedience (p=0,043). The disobedience of doctors to 
the principle of treatment that caused mortality rate by 
14.3% was due to delays in empiric antibiotics, non-
bactericidal empirical or narrow-spectrum antibiotics, 
and consent from the third party. Other possibilities 
were patients came on holiday and that constrained the 
agreement problem with the person in charge and the 
availability of antibiotic in pharmaceutical installation 
was limited.  
Although patients should receive their initial 
treatment within an hour of presentation to an 
emergency department, this goal was problematic for 
many reasons, in both clinical and administrative ways. 
For example, patients must be properly evaluated with 
laboratory tests and radiographs to determine 
neutropenia and to identify a possible source of 
infection
 
(10). Meisenberg et al. showed the longest 
delayed treatment were a consequence of the conscious 
or functional decision to pause the delivery of 
antibiotics while awaiting transfer to an inpatient unit. 
This delayed treatment is a result of lack of appreciation 
for the pathophysiology of infection and potential sepsis 
(11). 
To answer the objectives of this study, a multivariate 
analysis should be established. Because there was only 
one variable (adherence to management algorithm) that 
was significant, multivariate analysis was not done. 
 
CONCLUSIONS 
 
The mortality rate of febrile neutropenia fever in 
isolation room during 2008-2012 (20.7%) in isolation 
room, Dharmais Hospital-National Cancer Center was 
decreased compared to year 2000 (22.5%) and 2002 
(38.8%). The correlation of age, sex, and degree of risk 
factors did not differ significantly to mortality (p=0,477; 
0,404; 0,324). The proportion of mortality rates was 
higher in case with the third person in charge (26.8%) 
than private (10%) although statistically was not 
significant (p=0,065). From the three types of 
adherence, only adherence to the management 
algorhytm of treatment that had a significant effect on 
mortality rate (p=0,033). A significant parameter in this 
case is to stop antibiotic/antifungal treatment according 
to the degree of risk. This was caused by the doctors in 
charge in isolation room that were consultant of 
hematology and medical oncology who had the 
competence, awareness, and understanding of the 
guideline. 
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